- Research works
- 42 ▲ 15% vs 2013–17
- Citations
- 387 9.2 per fractional work
- Top-10% rate
- 18.9% record average 16.5%
- Open access
- 56% world 28%
Not ranked overall: AbbVie (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.7×. Every wedge is a field page.
- Immunology and Microbiology 6.7×
- Medicine 3.8×
- Economics, Econometrics and Finance 3.5×
- Pharmacology, Toxicology and Pharmaceutics 3.2×
- Dentistry 2.5×
- Biochemistry, Genetics and Molecular Biology 1.1×
- Psychology 0.5×
- Neuroscience 0.5×
- Decision Sciences 0.4×
- Chemistry 0.4×
- Mathematics 0.3×
- Health Professions 0.3×
- Environmental Science 0.1×
- Engineering 0.0×
Which keywords describe research at AbbVie (United Kingdom)?
By fractional works in all years, weighted toward what it does more of than the world: Quality of Life, Epidemiology, Inflammatory Bowel Disease, Autoantibodies, Inflammation, Economic Evaluation, Cardiovascular Risk and Cost-effectiveness Analysis.
- TH17 Cells
- IL-17
- Regulatory T Cells
- Microscopic Colitis
- Hyaluronic Acid
- Collagenous Colitis
- Biopharmaceuticals
- Curriculum
- Cosmetic Surgery
- Treatment
- Medical Education
- Ulcerative Colitis
- Neurological Disorders
- Genetics
- Biological Therapy
- Rheumatoid Arthritis
- Cost-effectiveness Analysis
- Economic Evaluation
- Inflammatory Bowel Disease
- Quality of Life
- Epidemiology
- Inflammation
- Autoantibodies
- Cardiovascular Risk
- Health Utility Measures
- Cytokines
- Disease-Modifying Antirheumatic Drugs
- Pathogenesis
- Crohn's Disease
- Complications
- Primary Care
- Clinical Trials
- Pharmaceutical Industry
- Musculoskeletal Medicine
- Clinical Outcomes
- Dermal Fillers
- Inflammatory Cytokines
- Monoclonal Antibodies
- Ankylosing Spondylitis
- Spondyloarthritis
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology6▲ 3.5×26 topics
- Quality of Life4▲ 8.0×13 topics
- Inflammation4▲ 4.0×13 topics
- Inflammatory Bowel Disease3▲ 75×4 topics
- Autoantibodies3▲ 32×4 topics
- Economic Evaluation3▲ 51×2 topics
- Cardiovascular Risk3▲ 18×3 topics
- Cost-effectiveness Analysis3▲ 81×1 topic
- Health Utility Measures3▲ 81×1 topic
- Rheumatoid Arthritis3▲ 61×2 topics
- Cytokines2▲ 22×3 topics
- Biological Therapy2▲ 104×1 topic
- Disease-Modifying Antirheumatic Drugs2▲ 119×1 topic
- Genetics2▲ 6.9×4 topics
- Pathogenesis2▲ 9.1×4 topics
- Neurological Disorders2▲ 7.0×5 topics
- Crohn's Disease2▲ 56×1 topic
- Ulcerative Colitis2▲ 129×1 topic
- Complications2▲ 8.2×4 topics
- Medical Education2▲ 18×4 topics
- Primary Care2▲ 10×6 topics
- Treatment2▲ 3.4×10 topics
- Clinical Trials2▲ 5.6×5 topics
- Cosmetic Surgery1▲ 101×2 topics
- Pharmaceutical Industry1▲ 82×2 topics
- Curriculum1▲ 33×1 topic
- Musculoskeletal Medicine1▲ 183×1 topic
- Biopharmaceuticals1▲ 41×2 topics
- Clinical Outcomes1▲ 14×2 topics
- Collagenous Colitis1▲ 111×1 topic
- Dermal Fillers1▲ 156×1 topic
- Hyaluronic Acid1▲ 156×1 topic
- Inflammatory Cytokines1▲ 39×2 topics
- Microscopic Colitis1▲ 111×1 topic
- Monoclonal Antibodies1▲ 20×2 topics
- Regulatory T Cells1▲ 25×2 topics
- Ankylosing Spondylitis1▲ 121×1 topic
- IL-171▲ 106×1 topic
- Spondyloarthritis1▲ 121×1 topic
- TH17 Cells1▲ 106×1 topic
Which research topics does AbbVie (United Kingdom) publish most on?
By volume in 2022–2025: Facial Rejuvenation and Surgery Techniques, Dermatologic Treatments and Research, Inflammatory Bowel Disease and Health Systems, Economic Evaluations, Quality of Life.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Facial Rejuvenation and Surgery Techniques Dermatology 1 works
- 2 Dermatologic Treatments and Research Dermatology 1 works
- 3 Inflammatory Bowel Disease Genetics 1 works
- 4 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 5 Psoriasis: Treatment and Pathogenesis Immunology 1 works
- 6 Migraine and Headache Studies Psychiatry and Mental health 1 works
- 7 Rheumatoid Arthritis Research and Therapies Rheumatology 0 works
- 8 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
- 9 Botulinum Toxin and Related Neurological Disorders Neurology 0 works
- 10 Body Contouring and Surgery Surgery 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has AbbVie (United Kingdom)'s research output changed?
Output in 2018–2022 was 15% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Maidenhead
- Abbott (United Kingdom)
- Berkshire College of Agriculture
- Institute of Clinical Research
- Huntercombe Hospital
- Costain (United Kingdom)
- Biogen (United Kingdom)
- NSK (United Kingdom)
- Zogenix (United Kingdom)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.